Harman Patil (Editor)

Pankomab

Updated on
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Covid-19
Type  Whole antibody
ATC code  none
Source  Humanized (from mouse)
ChemSpider  none
Target  tumor specific glycosylation of MUC1
Synonyms  PankoMab-GEX, anti-TA-MUC1

PankoMab is a humanized monoclonal antibody recognizing the tumor-specific epitope of mucin-1 (TA-MUC1), enabling it to differentiate between tumor MUC1 and non-tumor MUC1 epitopes. PankoMab is being developed by Glycotope GMBH and is currently undergoing a phase II clinical trial for ovarian cancer

References

Pankomab Wikipedia


Topics
 
B
i
Link
H2
L